Abstract

Summary

This paper reviews neuroprotective strategies for glaucoma, framing it as a CNS neurodegenerative disease affecting retinal ganglion cells (RGCs), which are also the substrate for non-visual light sensing via ipRGCs. For lighting designers and healthcare providers, preserving RGC health is critical not only for vision but also for maintaining circadian photoentrainment capacity in aging patients.
Abstract

Key Findings

  • Glaucoma is characterized by progressive RGC loss, which the authors argue classifies it as a neurodegenerative CNS disease rather than solely an ocular condition.
  • Neuroprotective strategies reviewed include targeting glutamate excitotoxicity, oxidative stress, and neurotrophic factor deprivation as pathways to slow RGC degeneration.
  • The paper supports the hypothesis that glaucomatous damage extends beyond the eye to affect central visual pathways, with implications for broader neurological function.
Categories

Categories

Eye Health & Vision: Focuses on retinal ganglion cell neuroprotection in glaucoma, directly relevant to photoreceptor and RGC health in the visual system.
Dementia & Elder Care: Discusses glaucoma as a neurodegenerative disease with implications for aging populations and CNS neurodegeneration parallels.
Authors

Author(s)

C Nucci, R Russo, A Martucci, C Giannini
Publication Date

Publication Year

2016
Citations

Number of Citations

59
View more publications